-
1
-
-
77956055481
-
Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
-
Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010, 62:2569-2581.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 2569-2581
-
-
Aletaha, D.1
Neogi, T.2
Silman, A.J.3
Funovits, J.4
Felson, D.T.5
Bingham, C.O.6
-
2
-
-
0035990221
-
Prevalence of rheumatoid arthritis in Tucumán, Argentina
-
Spindler A., Bellomio V., Berman A., Lucero E., Baigorria M., Paz S., et al. Prevalence of rheumatoid arthritis in Tucumán, Argentina. J Rheumatol 2002, 29:1166-1170.
-
(2002)
J Rheumatol
, vol.29
, pp. 1166-1170
-
-
Spindler, A.1
Bellomio, V.2
Berman, A.3
Lucero, E.4
Baigorria, M.5
Paz, S.6
-
3
-
-
84891661327
-
Health care utilization and direct medical costs in patients with rheumatoid arthritis in a developing country
-
Soriano E.R., Castel del Cid C., Devoto F., Imamura P., Catoggio L. Health care utilization and direct medical costs in patients with rheumatoid arthritis in a developing country. Rheumatology 2005, 44:i54.
-
(2005)
Rheumatology
, vol.44
-
-
Soriano, E.R.1
Castel del Cid, C.2
Devoto, F.3
Imamura, P.4
Catoggio, L.5
-
4
-
-
78049287592
-
The prevalence of rheumatoid arthritis in Argentina: a capture-recapture study in a city in Buenos Aires province
-
Scublinsky D., Venarotti H., Citera G., Messina O.D., Scheines E., Rillo O., et al. The prevalence of rheumatoid arthritis in Argentina: a capture-recapture study in a city in Buenos Aires province. J Clin Rheumatol 2010, 16:317-321.
-
(2010)
J Clin Rheumatol
, vol.16
, pp. 317-321
-
-
Scublinsky, D.1
Venarotti, H.2
Citera, G.3
Messina, O.D.4
Scheines, E.5
Rillo, O.6
-
5
-
-
78650894724
-
Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology
-
Peláez-Ballestas I., Sanin L.H., Moreno-Montoya J., Alvarez-Nemegyei J., Burgos-Vargas R., Garza-Elizondo M., et al. Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol Suppl 2011, 86:3-8.
-
(2011)
J Rheumatol Suppl
, vol.86
, pp. 3-8
-
-
Peláez-Ballestas, I.1
Sanin, L.H.2
Moreno-Montoya, J.3
Alvarez-Nemegyei, J.4
Burgos-Vargas, R.5
Garza-Elizondo, M.6
-
6
-
-
0036708856
-
Community based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. A COPCORD study
-
Cardiel M.H., Rojas-Serrano J. Community based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. A COPCORD study. Clin Exp Rheum 2002, 20:617-662.
-
(2002)
Clin Exp Rheum
, vol.20
, pp. 617-662
-
-
Cardiel, M.H.1
Rojas-Serrano, J.2
-
7
-
-
38449094674
-
Latitude gradient influences the age of onset of rheumatoid arthritis patients
-
Ramos-Remus C., Sierra-Jimenez G., Skeith K., Aceves-Avila F.J., Russell A.S., Offer R., et al. Latitude gradient influences the age of onset of rheumatoid arthritis patients. Clin Rheumatol 2007, 26:1725-1728.
-
(2007)
Clin Rheumatol
, vol.26
, pp. 1725-1728
-
-
Ramos-Remus, C.1
Sierra-Jimenez, G.2
Skeith, K.3
Aceves-Avila, F.J.4
Russell, A.S.5
Offer, R.6
-
8
-
-
50849109500
-
Challenges in the management of rheumatoid arthritis in developing countries
-
Mody G.M., Cardiel M.H. Challenges in the management of rheumatoid arthritis in developing countries. Best Pract Res Clin Rheumatol 2008, 22:621-641.
-
(2008)
Best Pract Res Clin Rheumatol
, vol.22
, pp. 621-641
-
-
Mody, G.M.1
Cardiel, M.H.2
-
9
-
-
84875374191
-
-
Bloomberg School of Public Health, Johns Hopkins University. Non-communicable chronic diseases in Latin America and the Caribbean. The Healthy Caribbean Coalition Website: [accessed 13.11.11].
-
Bloomberg School of Public Health, Johns Hopkins University. Non-communicable chronic diseases in Latin America and the Caribbean. The Healthy Caribbean Coalition Website: [accessed 13.11.11]. http://www.healthycaribbean.org/publications/documents/NCD-in-LAC-USAID.pdf.
-
-
-
-
10
-
-
79955631079
-
The burden of illness of rheumatoid arthritis
-
Boonen A., Severens J.L. The burden of illness of rheumatoid arthritis. Clin Rheumatol 2011, 30:S3-S8.
-
(2011)
Clin Rheumatol
, vol.30
-
-
Boonen, A.1
Severens, J.L.2
-
11
-
-
54449098621
-
Social costs of the most common inflammatory rheumatic disease in Mexico from the patient's perspective
-
Mould-Quevedo J., Peláez-Ballestas I., Vásquez-Mellado J., Terán-Estrada L., Esquivel-Valerio J., Ventura-Ríos L., et al. Social costs of the most common inflammatory rheumatic disease in Mexico from the patient's perspective. Gac Med Mex 2008, 144:225-231.
-
(2008)
Gac Med Mex
, vol.144
, pp. 225-231
-
-
Mould-Quevedo, J.1
Peláez-Ballestas, I.2
Vásquez-Mellado, J.3
Terán-Estrada, L.4
Esquivel-Valerio, J.5
Ventura-Ríos, L.6
-
12
-
-
84863309865
-
Catastrophic expenses and rate of impoverishment as consequence of the cost of rheumatoid arthritis
-
Álvarez-Hernández E., Pelaez-Ballestas I., Boonen A., Vázquez-Mellado J., Hernández-Garduño A., Carlos F., et al. Catastrophic expenses and rate of impoverishment as consequence of the cost of rheumatoid arthritis. Reumatol Clin 2012, 8:168-173.
-
(2012)
Reumatol Clin
, vol.8
, pp. 168-173
-
-
Álvarez-Hernández, E.1
Pelaez-Ballestas, I.2
Boonen, A.3
Vázquez-Mellado, J.4
Hernández-Garduño, A.5
Carlos, F.6
-
13
-
-
33745795536
-
Factors associated with permanent work disability in Mexican patients with rheumatoid arthritis. A case control study
-
Morales-Romero J., Gonzales-Lopez L., Celis A., Rodriguez-Arreola B.E., Cabrera-Pivaral C.E., Gamez-Nava J.I. Factors associated with permanent work disability in Mexican patients with rheumatoid arthritis. A case control study. J Rheumatol 2006, 33:1247-1249.
-
(2006)
J Rheumatol
, vol.33
, pp. 1247-1249
-
-
Morales-Romero, J.1
Gonzales-Lopez, L.2
Celis, A.3
Rodriguez-Arreola, B.E.4
Cabrera-Pivaral, C.E.5
Gamez-Nava, J.I.6
-
14
-
-
0034062017
-
The costs of rheumatoid arthritis: an international long-term view
-
Pugner K.M., Scott D.I., Holmes J.W., Hieke K. The costs of rheumatoid arthritis: an international long-term view. Semin Arthritis Rheum 2000, 29:305-320.
-
(2000)
Semin Arthritis Rheum
, vol.29
, pp. 305-320
-
-
Pugner, K.M.1
Scott, D.I.2
Holmes, J.W.3
Hieke, K.4
-
15
-
-
84891661046
-
Utilización de medicinas alternativas en la consulta reumatológica en la ciudad de Barranquilla
-
Caballero-Uribe C., Wilches H., Wilches K., Rojas J., Salas Siado J., Forero E., et al. Utilización de medicinas alternativas en la consulta reumatológica en la ciudad de Barranquilla. Rev Col Rheumatol 2002, 9:194-200.
-
(2002)
Rev Col Rheumatol
, vol.9
, pp. 194-200
-
-
Caballero-Uribe, C.1
Wilches, H.2
Wilches, K.3
Rojas, J.4
Salas Siado, J.5
Forero, E.6
-
16
-
-
79951698249
-
General characteristics of an early arthritis cohort in Argentina
-
Marcos J., Waimann C., Dal Pra F., Hogrefe J., Retamozo S., Caeiro F., et al. General characteristics of an early arthritis cohort in Argentina. Rheumatology (Oxford) 2011, 50:110-116.
-
(2011)
Rheumatology (Oxford)
, vol.50
, pp. 110-116
-
-
Marcos, J.1
Waimann, C.2
Dal Pra, F.3
Hogrefe, J.4
Retamozo, S.5
Caeiro, F.6
-
17
-
-
38449083553
-
The burden of rheumatoid arthritis and access to treatment: health burden and costs
-
Lundkvist J., Kastäng F., Kobelt G. The burden of rheumatoid arthritis and access to treatment: health burden and costs. Eur J Health Econ 2008, 8:S49-S60.
-
(2008)
Eur J Health Econ
, vol.8
-
-
Lundkvist, J.1
Kastäng, F.2
Kobelt, G.3
-
18
-
-
68049127280
-
Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database
-
Sokka T., Kautiainen H., Pincus T., Toloza S., da Rocha Castelar Pinheiro G., Lazovskis J., et al. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis 2009, 68:1666-1672.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1666-1672
-
-
Sokka, T.1
Kautiainen, H.2
Pincus, T.3
Toloza, S.4
da Rocha Castelar Pinheiro, G.5
Lazovskis, J.6
-
19
-
-
33747044702
-
First Latin American position paper on the pharmacological treatment of rheumatoid arthritis
-
Cardiel M.H. First Latin American position paper on the pharmacological treatment of rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:ii7-ii22.
-
(2006)
Rheumatology (Oxford)
, vol.45
-
-
Cardiel, M.H.1
-
20
-
-
67650930350
-
Management of patients with rheumatoid arthritis in Latin America. A Consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano de Estudio de Artritis Reumatoide
-
Massardo L., Suarez-Almazor M.E., Cardiel M.H., Nava A., Levy R.A., Laurindo I., et al. Management of patients with rheumatoid arthritis in Latin America. A Consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano de Estudio de Artritis Reumatoide. J Clin Rheumatol 2009, 15:203-210.
-
(2009)
J Clin Rheumatol
, vol.15
, pp. 203-210
-
-
Massardo, L.1
Suarez-Almazor, M.E.2
Cardiel, M.H.3
Nava, A.4
Levy, R.A.5
Laurindo, I.6
-
21
-
-
45749112561
-
Guidelines. Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context
-
Soriano E.R., Galarza-Maldonado C., Cardiel M.H., Pons-Estel B.A., Massardo L., Caballero-Uribe C.V., et al. Guidelines. Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context. Rheumatology 2008, 47:1097-1099.
-
(2008)
Rheumatology
, vol.47
, pp. 1097-1099
-
-
Soriano, E.R.1
Galarza-Maldonado, C.2
Cardiel, M.H.3
Pons-Estel, B.A.4
Massardo, L.5
Caballero-Uribe, C.V.6
-
22
-
-
84875374912
-
-
Sociedad Argentina de Reumatología. Guías argentinas de práctica clínica en el tratamiento de la artritis reumatoide: Actualización. Revista Argentina de Reumatología. [accessed 04.04.12].
-
Sociedad Argentina de Reumatología. Guías argentinas de práctica clínica en el tratamiento de la artritis reumatoide: Actualización. Revista Argentina de Reumatología. [accessed 04.04.12]. http://www.reumatologia.org.ar/userfiles/file/publicaciones/revista-reumatologia/SAR_GuiasTCZ_2011.pdf.
-
-
-
-
23
-
-
51649109138
-
Update on the Brazilian consensus for the diagnosis and treatment of rheumatoid arthritis
-
Bertolo M.B., Brenol C.V., Schainberg C.G., Neubarth F., de Lima F., Laurindo I.M., et al. Update on the Brazilian consensus for the diagnosis and treatment of rheumatoid arthritis. Rev Bras Reumatol 2007, 47:151-159.
-
(2007)
Rev Bras Reumatol
, vol.47
, pp. 151-159
-
-
Bertolo, M.B.1
Brenol, C.V.2
Schainberg, C.G.3
Neubarth, F.4
de Lima, F.5
Laurindo, I.M.6
-
24
-
-
79955537882
-
-
Ministerio de Salud, MINSAL, Santiago, [accessed 04.04.12]
-
Guía Clínica Artritis Reumatoidea 2007, Ministerio de Salud, MINSAL, Santiago, [accessed 04.04.12]. http://www.redsalud.gov.cl/archivos/guiasges/artritispdf.pdf.
-
(2007)
Guía Clínica Artritis Reumatoidea
-
-
-
25
-
-
84875373209
-
-
Asociación Colombiana de Reumatología, Exlibris Editores SA, DC Bogota, [accessed 04.04.12]
-
Guías para el tratamiento de la artritis reumatoide 2002, Asociación Colombiana de Reumatología, Exlibris Editores SA, DC Bogota, [accessed 04.04.12]. http://dnn.asoreuma.org/Portals/0/Descargas/GUIA%20PARA%20EL%20TRATAMIENTO%20DE%20LA%20AR%20Parte%201.pdf.
-
(2002)
Guías para el tratamiento de la artritis reumatoide
-
-
-
26
-
-
84891664189
-
Costa Rican Association of Rheumatology Guías de manejo de la artritis reumatoide Concenso 2010
-
Costa Rican Association of Rheumatology Guías de manejo de la artritis reumatoide Concenso 2010. Acta Med Costarric 2011, 53:19-25.
-
(2011)
Acta Med Costarric
, vol.53
, pp. 19-25
-
-
-
27
-
-
33646554170
-
Colegio Mexicano de Reumatología. Guías y recomendaciones del Colegio Mexicano de Reumatología para el uso de agentes biológicos en enfermos reumáticos
-
Comité Mexicano del Consenso de Biológicos
-
Colegio Mexicano de Reumatología. Guías y recomendaciones del Colegio Mexicano de Reumatología para el uso de agentes biológicos en enfermos reumáticos. Reumatol Clin 2006, 2:78-89. Comité Mexicano del Consenso de Biológicos.
-
(2006)
Reumatol Clin
, vol.2
, pp. 78-89
-
-
-
28
-
-
84875373651
-
-
Instituto Mexicano del Seguro Social. Guia de Referencia Rapida: Diagnostico y Tratamiento de Artritis Rheumatoide del Adulto. IMSS Website: [accessed 04.04.12].
-
Instituto Mexicano del Seguro Social. Guia de Referencia Rapida: Diagnostico y Tratamiento de Artritis Rheumatoide del Adulto. IMSS Website: [accessed 04.04.12]. http://www.cvsp.cucs.udg.mx/guias/TODAS/IMSS_195_08_ARTRITIS_REUMATOIDE/IMSS_195_08_GRR.pdf.
-
-
-
-
29
-
-
69949168726
-
Very recent onset arthritis: the value of initial rheumatologist and anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis
-
Rojas-Serrano J., Burgos-Vargas R., Lino Perez L., García C.G., Moctezuma F., Vázquez-Mellado J. Very recent onset arthritis: the value of initial rheumatologist and anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Rheumatol 2009, 28:1135-1139.
-
(2009)
Clin Rheumatol
, vol.28
, pp. 1135-1139
-
-
Rojas-Serrano, J.1
Burgos-Vargas, R.2
Lino Perez, L.3
García, C.G.4
Moctezuma, F.5
Vázquez-Mellado, J.6
-
30
-
-
3242677099
-
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
-
Grigor C., Capell H., Stirling A., McMahon A.D., Lock P., Vallance R., et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004, 364:263-269.
-
(2004)
Lancet
, vol.364
, pp. 263-269
-
-
Grigor, C.1
Capell, H.2
Stirling, A.3
McMahon, A.D.4
Lock, P.5
Vallance, R.6
-
31
-
-
79952362560
-
Disease activity score-driven therapy versus routine care in patients with recent onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort
-
Soubrier M., Lukas C., Sibilia J., Fautrel B., Roux F., Gossec L., et al. Disease activity score-driven therapy versus routine care in patients with recent onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort. Ann Rheum Dis 2011, 70:611-615.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 611-615
-
-
Soubrier, M.1
Lukas, C.2
Sibilia, J.3
Fautrel, B.4
Roux, F.5
Gossec, L.6
-
32
-
-
84891664026
-
National Center of Rheumatic Disease (CNER). Early inflammatory polyarthritis
-
Nuñez-Sotelo M., Gutierrez-Gonzalez L.A., Gonzalez N., Losada B. National Center of Rheumatic Disease (CNER). Early inflammatory polyarthritis. J Med Archiv 2007, 21:125-137.
-
(2007)
J Med Archiv
, vol.21
, pp. 125-137
-
-
Nuñez-Sotelo, M.1
Gutierrez-Gonzalez, L.A.2
Gonzalez, N.3
Losada, B.4
-
33
-
-
33846001961
-
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
-
Combe B., Landewe R., Lukas C., Bolosiu H.D., Breedveld F., Dougados M., et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007, 66:34-45.
-
(2007)
Ann Rheum Dis
, vol.66
, pp. 34-45
-
-
Combe, B.1
Landewe, R.2
Lukas, C.3
Bolosiu, H.D.4
Breedveld, F.5
Dougados, M.6
-
34
-
-
84875375113
-
-
Registro Panamericano de acontecimientos adversos de terapias biológicas en enfermedades reumáticas. BIOBADASER Website: [accessed 07.11.11].
-
Registro Panamericano de acontecimientos adversos de terapias biológicas en enfermedades reumáticas. BIOBADASER Website: [accessed 07.11.11]. https://biobadaser.ser.es/biobadamerica/.
-
-
-
-
35
-
-
48149100741
-
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomized, double-blind, parallel treatment trial
-
Emery P., Breedveld F.C., Hall S., Durez P., Chang D.J., Robertson D., et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomized, double-blind, parallel treatment trial. Lancet 2008, 372:375-382.
-
(2008)
Lancet
, vol.372
, pp. 375-382
-
-
Emery, P.1
Breedveld, F.C.2
Hall, S.3
Durez, P.4
Chang, D.J.5
Robertson, D.6
-
36
-
-
9144264155
-
Infliximab in active early rheumatoid arthritis
-
Breedveld F.C., Emery P., Keystone E., Patel K., Furst D.E., Kalden J.R., et al. Infliximab in active early rheumatoid arthritis. Ann Rheum Dis 2004, 63:149-155.
-
(2004)
Ann Rheum Dis
, vol.63
, pp. 149-155
-
-
Breedveld, F.C.1
Emery, P.2
Keystone, E.3
Patel, K.4
Furst, D.E.5
Kalden, J.R.6
-
37
-
-
31044442965
-
The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
-
Breedveld F.C., Weisman M.H., Kavanaugh A.F., Cohen S.B., Pavelka K., van Vollenhoven R., et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006, 54:26-37.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 26-37
-
-
Breedveld, F.C.1
Weisman, M.H.2
Kavanaugh, A.F.3
Cohen, S.B.4
Pavelka, K.5
van Vollenhoven, R.6
-
38
-
-
79953711736
-
B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study
-
Sellam J., Hendel-Chavez H., Rouanet S., Abbed K., Combe B., Le Loët X., et al. B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study. Arthritis Rheum 2011, 63:933-938.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 933-938
-
-
Sellam, J.1
Hendel-Chavez, H.2
Rouanet, S.3
Abbed, K.4
Combe, B.5
Le Loët, X.6
-
39
-
-
24944498854
-
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition [published correction appears in N Engl J Med 2005;353:2311]
-
Genovese M.C., Becker J.C., Schiff M., Luggen M., Sherrer Y., Kremer J., et al. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition [published correction appears in N Engl J Med 2005;353:2311]. N Engl J Med 2005, 353:1114-1123.
-
(2005)
N Engl J Med
, vol.353
, pp. 1114-1123
-
-
Genovese, M.C.1
Becker, J.C.2
Schiff, M.3
Luggen, M.4
Sherrer, Y.5
Kremer, J.6
-
40
-
-
52149099504
-
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial [published correction appears in Ann Rheum Dis 2009;68:296]
-
Emery P., Keystone E., Tony H.P., Cantagre A., van Vollenhoven R., Sanchez A., et al. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial [published correction appears in Ann Rheum Dis 2009;68:296]. Ann Rheum Dis 2008, 67:1516-1523.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 1516-1523
-
-
Emery, P.1
Keystone, E.2
Tony, H.P.3
Cantagre, A.4
van Vollenhoven, R.5
Sanchez, A.6
-
41
-
-
53649101010
-
Emerging therapeutics for rheumatoid arthritis
-
Bingham C.O. Emerging therapeutics for rheumatoid arthritis. Bull NYU Hosp Jt Dis 2008, 66:210-215.
-
(2008)
Bull NYU Hosp Jt Dis
, vol.66
, pp. 210-215
-
-
Bingham, C.O.1
-
42
-
-
77955339521
-
New and emerging therapies for the treatment of rheumatoid arthritis
-
Feely M.G. New and emerging therapies for the treatment of rheumatoid arthritis. Open Access Rheumatol Res Rev 2010, 2:35-43.
-
(2010)
Open Access Rheumatol Res Rev
, vol.2
, pp. 35-43
-
-
Feely, M.G.1
-
43
-
-
84862272498
-
Tofacitinib (CP-690,550), an oral janus kinase inhibitor, or adalimumab versus placebo in patients with rheumatoid arthritis on background methotrexate: a phase 3 study
-
van Vollenhoven R., Fleischmann R., Cohen S., Lee E.B., Meijide G., Wagner S., et al. Tofacitinib (CP-690,550), an oral janus kinase inhibitor, or adalimumab versus placebo in patients with rheumatoid arthritis on background methotrexate: a phase 3 study. Arthritis Rheum 2011, 63:S153.
-
(2011)
Arthritis Rheum
, vol.63
-
-
van Vollenhoven, R.1
Fleischmann, R.2
Cohen, S.3
Lee, E.B.4
Meijide, G.5
Wagner, S.6
-
44
-
-
77957333252
-
An oral spleen tyrosine kinase (SyK) inhibitor for rheumatoid arthritis
-
Weiblatt M.E., Kavanaugh A., Genovese M.C., Musser T.K., Grossbard E.B., Magilavy D.B. An oral spleen tyrosine kinase (SyK) inhibitor for rheumatoid arthritis. N Engl J Med 2010, 363:1303-1312.
-
(2010)
N Engl J Med
, vol.363
, pp. 1303-1312
-
-
Weiblatt, M.E.1
Kavanaugh, A.2
Genovese, M.C.3
Musser, T.K.4
Grossbard, E.B.5
Magilavy, D.B.6
-
45
-
-
67650379733
-
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicenter, randomized, double-blind, placebo-controlled, phase III trial
-
Smolen J.S., Kay J., Doyle M.K., Landewé R., Matteson E.L., Wollenhaupt J., et al. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicenter, randomized, double-blind, placebo-controlled, phase III trial. Lancet 2009, 374:210-221.
-
(2009)
Lancet
, vol.374
, pp. 210-221
-
-
Smolen, J.S.1
Kay, J.2
Doyle, M.K.3
Landewé, R.4
Matteson, E.L.5
Wollenhaupt, J.6
-
46
-
-
67449124634
-
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomized, controlled trial
-
Smolen J., Landewe R.B., Mease P., Brzezicki J., Mason D., Luijtens K., et al. Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomized, controlled trial. Ann Rheum Dis 2009, 68:797-804.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 797-804
-
-
Smolen, J.1
Landewe, R.B.2
Mease, P.3
Brzezicki, J.4
Mason, D.5
Luijtens, K.6
-
47
-
-
80053469218
-
Biosimilars: the debate continues
-
Colbert R.A., Cronstein B.N. Biosimilars: the debate continues. Arthritis Rheum 2011, 63:2848-2850.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 2848-2850
-
-
Colbert, R.A.1
Cronstein, B.N.2
-
48
-
-
39549105384
-
Scientific and legal viability of follow-on protein drugs
-
Dudzinski D.M., Kesselheim A.S. Scientific and legal viability of follow-on protein drugs. N Engl J Med 2008, 358:843-849.
-
(2008)
N Engl J Med
, vol.358
, pp. 843-849
-
-
Dudzinski, D.M.1
Kesselheim, A.S.2
-
49
-
-
82155188444
-
Biosimilars: a regulatory perspective from America
-
Kay J. Biosimilars: a regulatory perspective from America. Arthritis Res Ther 2011, 13:112.
-
(2011)
Arthritis Res Ther
, vol.13
, pp. 112
-
-
Kay, J.1
-
50
-
-
80051984166
-
Biosimilars of biological drugs therapies, regulatory, clinical and commercial considerations
-
Dranitsaris G., Amir E., Dorward K. Biosimilars of biological drugs therapies, regulatory, clinical and commercial considerations. Drugs 2011, 71:1527-1536.
-
(2011)
Drugs
, vol.71
, pp. 1527-1536
-
-
Dranitsaris, G.1
Amir, E.2
Dorward, K.3
-
51
-
-
84887909791
-
Mexico recovers leadership on regulation of biosimilar biotech drugs
-
López-Silva C. Mexico recovers leadership on regulation of biosimilar biotech drugs. Gac Med Mex 2012, 148:83-90.
-
(2012)
Gac Med Mex
, vol.148
, pp. 83-90
-
-
López-Silva, C.1
-
52
-
-
80055096139
-
Etanar therapy in real-life patients with rheumatoid arthritis
-
[abstract]
-
Rondon F., Bautista A., Salazar J.C., Casas N., Santos P., Vargas F., et al. Etanar therapy in real-life patients with rheumatoid arthritis. Arthritis Rheum 2010, 62(Suppl. 10):1811. [abstract].
-
(2010)
Arthritis Rheum
, vol.62
, Issue.SUPPL. 10
, pp. 1811
-
-
Rondon, F.1
Bautista, A.2
Salazar, J.C.3
Casas, N.4
Santos, P.5
Vargas, F.6
-
53
-
-
84875376104
-
-
Dr Reddy's brand of rituximab. Dr Reddy's Laboratories Inc. Website: [accessed 04.04.12].
-
Dr Reddy's brand of rituximab. Dr Reddy's Laboratories Inc. Website: [accessed 04.04.12]. http://www.drreddys.com/products/pdf/bio/Reditux-splash.pdf.
-
-
-
-
54
-
-
84875378513
-
-
TL011 in Severe, Active Rheumatoid Arthritis Patients. Clinical Trials Website: Accessed February 7
-
TL011 in Severe, Active Rheumatoid Arthritis Patients. Clinical Trials Website: Accessed February 7, 2012. http://www.clinicaltrials.gov/ct2/show/NCT01123070%3Fterm=TEVA%26cond=arthritis%26rank=2.
-
(2012)
-
-
-
55
-
-
84875376167
-
-
Yisaipu Website: [accessed 22.08.12].
-
Yisaipu Website: [accessed 22.08.12]. http://www.yisaipu.com/DiseaseList.aspx%3Fcate_id=20%26topCateID1=20%26topCateID=15.
-
-
-
-
56
-
-
84875379103
-
-
PRX-106. Protalix Biotherapeutics Website: [accessed 04.04.12].
-
PRX-106. Protalix Biotherapeutics Website: [accessed 04.04.12]. http://www.protalix.com/product-development/prx-106.asp.
-
-
-
-
57
-
-
84875379073
-
-
Pipelines. LG Life Sciences Website: [accessed 04.04.12].
-
Pipelines. LG Life Sciences Website: [accessed 04.04.12]. http://www.lgls.com/rd/pipeline.jsp.
-
-
-
|